In addition, preliminary experiments in pancreatic cancer tissue culture cell lines demonstrate that the activin neutralizing antibody blocks activin functions as measured by a decrease in SMAD2 phosphorylation (data not shown). The gene discussed is INHBE; the disease is pancreatic neoplasm.